Gene · 5394
Papers1,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multiple Acyl-Coenzyme A Dehydrogenase Deficiency Leading to Severe Metabolic Acidosis in a Young Adult. | AACE Clin Case Rep | 2023 | 36654993 | PubTator, text mining | PubMed |
| The TFIIS N-terminal domain (TND): a transcription assembly module at the interface of order and disorder. | Biochem Soc Trans | 2023 | 36651856 | PubTator, text mining | PubMed |
| Specific Autoantibodies and Microvascular Damage Progression Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: Are There Peculiar Associations? An Update. | Antibodies (Basel) | 2023 | 36648887 | PubTator, text mining | PubMed |
| Deciphering the Autoantibody Response to the OJ Antigenic Complex. | Diagnostics (Basel) | 2023 | 36611448 | PubTator, text mining | PubMed |
| Dissecting Trypanosoma brucei RRP44 function in the maturation of segmented ribosomal RNA using a regulated genetic complementation system. | Nucleic Acids Res | 2023 | 36610751 | PubTator, text mining | PubMed |
| Diagnostic accuracy and predictive value of autoantibody profiles in patients with systemic sclerosis: a single-center study. | Clin Rheumatol | 2023 | 36604358 | PubTator, text mining | PubMed |
| Association Between Rheumatic Autoantibodies and Immune-Related Adverse Events. | Oncologist | 2023 | 36595378 | PubTator, text mining | PubMed |
| Progressive proximal muscle weakness with subacute onset in an elderly patient: a case report. | Rev Neurol | 2023 | 36544374 | PubTator, text mining | PubMed |
| The complement system and human autoimmune diseases. | J Autoimmun | 2023 | 36535812 | PubTator, text mining | PubMed |
| Systemic sclerosis. | Lancet | 2023 | 36442487 | PubTator, text mining | PubMed |
| Paraneoplastic Anti-Tif1-gamma Autoantibody-positive Dermatomyositis as Clinical Presentation of Hepatocellular Carcinoma Recurrence. | J Clin Transl Hepatol | 2023 | 36406323 | PubTator, text mining | PubMed |
| Discovery of RUF6 ncRNA-interacting proteins involved in P. falciparum immune evasion. | Life Sci Alliance | 2023 | 36379669 | PubTator, text mining | PubMed |
| Screening and characterization of myositis-related autoantibodies in COVID-19 patients. | Clin Transl Sci | 2023 | 36271647 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| Low expression of EXOSC2 protects against clinical COVID-19 and impedes SARS-CoV-2 replication. | Life Sci Alliance | 2023 | 36241425 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Low copy numbers of complement C4 and C4A deficiency are risk factors for myositis, its subgroups and autoantibodies. | Ann Rheum Dis | 2023 | 36171069 | PubTator, text mining | PubMed |
| YAP 5-methylcytosine modification increases its mRNA stability and promotes the transcription of exosome secretion-related genes in lung adenocarcinoma. | Cancer Gene Ther | 2023 | 36123390 | PubTator, text mining | PubMed |
| Two clusters of systemic lupus erythematosus patients with muscle involvement in a Chinese cohort. | Int J Rheum Dis | 2023 | 36117395 | PubTator, text mining | PubMed |
| Anti-PM-Scl antibodies-positive patients encompass three different groups with distinct prognoses. | Rheumatology (Oxford) | 2023 | 36063462 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5394/papers?page=11